Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates ...

HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

An Arizona research team is leading an international effort to test a new therapy for advanced melanoma, a deadly skin cancer.

PowerHeal® Bioelectric Bandages, featuring groundbreaking technology used for the past decade in hospitals and clinics for ...

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Dr Mona Mofid SAN DIEGO, CA, UNITED STATES, April 28, 2025 /EINPresswire / -- ThreeBestRated® updates its listings annually to ensu ...

A simple blood test could reveal who is at high risk of skin cancer recurrence after tumor-removal surgery ... the doctor ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...